Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease
| Status: | Completed |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/2/2016 |
| Start Date: | January 2007 |
| End Date: | June 2008 |
| Contact: | James J Matino, MD |
| Email: | jimanderin@yahoo.com |
| Phone: | 860-249-8595 |
Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective
study that will evaluate the results of surgical pore excision, curettage, and injection of
a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.
study that will evaluate the results of surgical pore excision, curettage, and injection of
a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.
In addition, the study will evaluate the credibility and reproducibility of results within
other surgeons trained to perform the procedure. Data collection will focus on
post-operative wound failure, infection ratwes, analgesic requirements, time lost from work
or school, wound care requirements, and 6 month recurrence rates. These outcomes will be
compared to outcomes using conventional pilonidal surgical intervention using published
data.
other surgeons trained to perform the procedure. Data collection will focus on
post-operative wound failure, infection ratwes, analgesic requirements, time lost from work
or school, wound care requirements, and 6 month recurrence rates. These outcomes will be
compared to outcomes using conventional pilonidal surgical intervention using published
data.
Inclusion Criteria:
- Any patient with pilonidal diseas
We found this trial at
1
site
Click here to add this to my saved trials
